Abiopharma

Tiziana Life Sciences Ltd. (TLSA) Files Form 6-K

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”

📋 Gat Amnon (Officer) plans to sell 62K shares of Alpha Tau Medical Ltd. (at $5.90 each, total $364K) Filed: Jan 08, 2026 | ID: 000008

(10% Negative) LIQUIDIA CORPORATION (LQDA) Announces Delay in million Trials for Liquidia Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update

(90% Positive) HAEMONETICS CORPORATION (HAE) Provides Update on approval for pre-close

New Form 15-12G - Merus N.V. Filed: 2026-01-09 AccNo: 0001193125-26-008212 Size: 11 KB

Haemonetics Acquires Vivasure Medical Limited